Pfizer, BioNTech to expand vaccine Phase 3 trial

US-based pharmaceutical major Pfizer and German biotech firm BioNTech have announced to expand the enrollment of their Phase 3 Covid-19 vaccine trial to up to approximately 44,000 participants, up from an initial recruitment goal of 30,000 individuals.

admin admin
Sep 13, 2020 - 17:34
41 0
Pfizer, BioNTech to expand vaccine Phase 3 trial
US-based pharmaceutical major Pfizer and German biotech firm BioNTech have announced to expand the enrollment of their Phase 3 Covid-19 vaccine trial to up to approximately 44,000 participants, up from an initial recruitment goal of 30,000 individuals.